Up And Down The Ladder… Job Changes
2 CommentsBy Ed Silverman // January 9th, 2008 // 7:52 am
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs being announced each month. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
MediZine named James Silverman as vp for sales and marketing;
ReachMD hired Paul Boidy as executive vp for biz development;
NeuroDiscovery hired Iain Chessell as group chief executive;
Pfizer hired Sally Susman as communications chief from Estee Lauder;
Merck hired Adele Ambrose as communications chief from AT&T Wireless;
Wyeth promoted Wendy Kouba to vp corporate communications;
ViroPharma named Tom Doyle as vp stratetgic initiatives;
ViroPharma promoted J. Peter Wolfe to general counsel;
Kosan hired Helen Kim as chief business officer;
Intercept named Luciano Adorini chief scientific officer;
Chimerix tapped Neil Frazer as chief medical officer;
NPS named Alan Harris chief medical officer;
Novo Nordisk promoted Alan Moses to vp, chief medical officer;
Access Pharmaceuticals appointed Jeff Davis as ceo;
Schering-Plough elected Craig Thompson as a director;
BioDelivery Sciences hired Charles Dadswell as general counsel;
Pharmos named Rober Johnston executive chairman of the board;
Pharmos also named S. Colin Neill as president;
Concert Pharma added Jim O’Shea and Dan Grau to its product advisory board;
Cerimon Pharma hired Matt Meyer as general counsel and vp biz development and licensing;
AngioGenex added Bill Garland to its board and named Richard Salvador as chairman.
Hat tip to Pharmaceutical Executive
Patrick Ronan
Patrick Ronan, former Food and Drug Administration (FDA)Chief of Staff under Dr. Andrew von Eschenbach and Dr. Les Crawford, resigned from Novartis Pharmaceuticals where he was Vice President Regulatory Policy & External Affairs.
Dona Wheeler
What goes up, must come down, it’s a law of physcics.
Drugs that set one up for a list of other ailments, putting a bandaid on the real issue… what can I add. It is time.